- IBM Japan and Toshiba have joined together with Japanese components manufacturer Taiyo Yuden to form a Bluetooth wireless venture for the Japanese market. The project will begin operations in April 2001.- 3Com and Extended Systems announced
- IBM Japan and Toshiba have joined together with Japanese components manufacturer Taiyo Yuden to form a Bluetooth wireless venture for the Japanese market. The project will begin operations in April 2001.
- 3Com and Extended Systems announced an agreement in August 2000 to jointly develop Bluetooth solutions for the Microsoft Windows platforms.
- Philips Components plans to form a Bluetooth hub through partnerships with Cambridge Silicon Radio, Intersil, Silicon Wave, and Widcomm to speed Bluetooth wireless products time-to-market.
- Hewlett-Packard has stepped up to lead the development of printing profiles for Bluetooth. HP's DeskJet, LaserJet, and PhotoSmart printer divisions will support the Bluetooth profile initiative.
- Registry Magic is creating customizable applications targeted at a range of market sectors that will be provided over partner Red-M's Bluetooth networking technology. Registry Magic's Bluetooth Consumer Payment Network uses biometric access security to transform Bluetooth-enabled cell phones into secure payment and identity authentication devices.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Study Shows Enhanced Diagnosis of Coronary Artery Stenosis with Photon-Counting CTA
July 10th 2025In a new study comparing standard resolution and ultra-high resolution modes for patients undergoing coronary CTA with photon-counting detector CT, researchers found that segment-level sensitivity and accuracy rates for diagnosing coronary artery stenosis were consistently > 89.6 percent.
FDA Expands Approval of MRI-Guided Ultrasound Treatment for Patients with Parkinson’s Disease
July 9th 2025For patients with advanced Parkinson’s disease, the expanded FDA approval of the Exablate Neuro platform allows for the use of MRI-guided focused ultrasound in performing staged bilateral pallidothalamic tractotomy.